The yield curve has inverted- what is it telling investors?
The US yield curve inverted for the first time since 2019, typically a sign that a recession is looming. Alex Rankine explains why this time may be different.

America’s recession alarm has sounded. The most watched part of the US yield curve – which plots the yields on different maturities of US government bonds – has briefly inverted for the first time since 2019.
In normal conditions, investors holding longer-duration bonds will demand higher yields than those holding shorter ones. But if markets think that interest rates in the future will be lower than they are now – eg, because a recession forces interest rate cuts – then the usual pattern can invert.
On Tuesday, yields on the two-year US Treasury note rose as high as 2.45%, a fraction above the 2.38% yield on the ten-year bond. Other parts of the curve, including the five-year to 30-year and the five-year to ten-year spreads, had already inverted, but the two-year to ten-year spread is the most closely watched. Previous inversions have predicted every US recession since the 1970s (although the curve has also sounded a few false alarms). The recessions usually follow between six to 24 months after the yield curve first inverts.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
This time really could be different
Yield-curve inversion might not be what it was. Some argue that the 2019 inversion, which heralded the Covid-19 recession the following year, was a fluke. Markets don’t possess magical epidemiological foresight. Certainly, central-bank quantitative easing (QE) programmes have distorted the bond market in recent years, says Shuli Ren on Bloomberg. “The yield curve is getting flatter by design”.
The US Federal Reserve has begun to raise interest rates, with markets expecting a cumulative 2% hike by the end of the year. That raises the yield on short-term government debt (such as the two-year Treasury note). At the same time, “until early March the central bank was still buying longer-dated Treasuries”, which depresses their yields. Financiers are used to taking an inverted yield curve as a “signal of impending doom”, but it may just be that central bank meddling “has broken the most reliable barometer of recession risks”.
“The yield curve’s recession signal is distorted,” agrees Michael Contopoulos of Richard Bernstein Advisors. Take away the US central bank’s “massive purchases” of government bonds and the “ten-year yield would be closer to 3.70%”, considerably higher than the current two-year yield and far off inverted. As the Fed unwinds QE, there is scope for longer-dated yields to rise.
The end of negative yields
Regardless of the shape of the curve, government bond yields have been climbing (and prices falling) across the board. “The Bloomberg Global Aggregate bond market index has lost over 11% since its peak in January 2021,” says Robin Wigglesworth in the Financial Times. The index has “lost $2.4trn in value so far in 2022”, reckons Matthew Hornbach of Morgan Stanley. As it does so, debt that yields less than 0% is also becoming rarer. In 2020 there were $18trn in “sub-zero” bonds globally (ie, investors effectively paid some governments and firms to borrow). As yields have risen, that figure is down to $2.9trn today. The yield curve may be giving unclear signals, but another bond-market distortion is more visibly unwinding.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves Published
-
Why you should review your cash ISA now
The start of the new tax year provides the perfect opportunity to take stock of your cash ISA savings, and make sure that your money is working as hard as it can
By Daniel Hilton Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine Published
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Large cap stocks start to struggle – is it time for investors to reassess their focus?
Buying quality large caps worked very well last decade. A more volatile world will be a bigger challenge for these star stocks, says Cris Sholto Heaton
By Cris Sholto Heaton Published